{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:43:20Z","timestamp":1777963400090,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Project of Basic Research for application of Science and Technology Department of Qinghai Province","award":["2019-ZJ-7003"],"award-info":[{"award-number":["2019-ZJ-7003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00432-022-03928-z","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:04:55Z","timestamp":1651212295000},"page":"1879-1892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Expression and clinical prognostic value of CYB561 in breast cancer"],"prefix":"10.1007","volume":"148","author":[{"given":"Xiaofeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GuoShuang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengfeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuxing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaozhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1266-8943","authenticated-orcid":false,"given":"Jiuda","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"3928_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043403","volume":"7","author":"S Akatsuka","year":"2012","unstructured":"Akatsuka S, Yamashita Y, Ohara H et al (2012) Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One 7:e43403. https:\/\/doi.org\/10.1371\/journal.pone.0043403","journal-title":"PLoS One"},{"key":"3928_CR2","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1200\/JCO.2015.63.9161","volume":"34","author":"F Andr\u00e9","year":"2016","unstructured":"Andr\u00e9 F, Hurvitz S, Fasolo A et al (2016) Molecular alterations and everolimus efficacy in human epidermal growth factor receptor 2-overexpressing metastatic breast cancers: combined exploratory biomarker analysis from BOLERO-1 and BOLERO-3. J Clin Oncol 34:2115\u20132124. https:\/\/doi.org\/10.1200\/JCO.2015.63.9161","journal-title":"J Clin Oncol"},{"key":"3928_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1089\/ars.2012.5065","volume":"19","author":"H Asard","year":"2013","unstructured":"Asard H, Barbaro R, Trost P et al (2013) Cytochromes b561: ascorbate-mediated trans-membrane electron transport. Antioxid Redox Signal 19:1026\u20131035. https:\/\/doi.org\/10.1089\/ars.2012.5065","journal-title":"Antioxid Redox Signal"},{"key":"3928_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41467-018-07729-2","volume":"10","author":"G Balmus","year":"2019","unstructured":"Balmus G, Pilger D, Coates J et al (2019) ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks. Nat Commun 10:87. https:\/\/doi.org\/10.1038\/s41467-018-07729-2","journal-title":"Nat Commun"},{"key":"3928_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"3928_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/9781118925645","volume-title":"Iron metabolism: from molecular mechanisms to clinical consequences","author":"R Crichton","year":"2016","unstructured":"Crichton R (2016) Iron metabolism: from molecular mechanisms to clinical consequences, 4th edn. Wiley. https:\/\/doi.org\/10.1002\/9781118925645","edition":"4"},{"key":"3928_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12916-015-0431-3","volume":"13","author":"S Dushyanthen","year":"2015","unstructured":"Dushyanthen S, Beavis PA, Savas P et al (2015) Relevance of tumor-infiltrating lymphocytes in breast cancer. BMC Med 13:202. https:\/\/doi.org\/10.1186\/s12916-015-0431-3","journal-title":"BMC Med"},{"key":"3928_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9:550\u2013962. https:\/\/doi.org\/10.1038\/nrc2664","journal-title":"Nat Rev Cancer"},{"key":"3928_CR9","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.7314\/apjcp.2015.16.14.6081","volume":"16","author":"M Ghoncheh","year":"2015","unstructured":"Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H (2015) Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J Cancer Prev 16:6081\u20136087. https:\/\/doi.org\/10.7314\/apjcp.2015.16.14.6081","journal-title":"Asian Pac J Cancer Prev"},{"key":"3928_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejca.2018.03.015","volume":"96","author":"E Gobbini","year":"2018","unstructured":"Gobbini E, Ezzalfani M, Dieras V et al (2018) Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. Eur J Cancer 96:17\u201324. https:\/\/doi.org\/10.1016\/j.ejca.2018.03.015","journal-title":"Eur J Cancer"},{"key":"3928_CR11","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1001\/jamaoncol.2017.0595","volume":"3","author":"D Huo","year":"2017","unstructured":"Huo D, Hu H, Rhie SK et al (2017) Comparison of breast cancer molecular features and survival by African and European ancestry in the cancer genome atlas. JAMA Oncol 3:1654\u20131662. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0595","journal-title":"JAMA Oncol"},{"key":"3928_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/bcmd.2002.0574","volume":"29","author":"GO Latunde-Dada","year":"2002","unstructured":"Latunde-Dada GO, Van der Westhuizen J, Vulpe CD et al (2002) Molecular and functional roles of duodenal cytochrome B (Dcytb) in iron metabolism. Blood Cells Mol Dis 29:356\u2013360. https:\/\/doi.org\/10.1006\/bcmd.2002.0574","journal-title":"Blood Cells Mol Dis"},{"key":"3928_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13058-017-0814-9","volume":"19","author":"DJ Lemler","year":"2017","unstructured":"Lemler DJ, Lynch ML, Tesfay L et al (2017) DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms. Breast Cancer Res 19:25. https:\/\/doi.org\/10.1186\/s13058-017-0814-9","journal-title":"Breast Cancer Res"},{"key":"3928_CR14","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"TW Li","year":"2017","unstructured":"Li TW, Fan JY, Wang BB et al (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Can Res 77:e108\u2013e110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307","journal-title":"Can Res"},{"key":"3928_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang H, Song X et al (2020) Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol 60:14\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.012","journal-title":"Semin Cancer Biol"},{"key":"3928_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/carcin\/bgt351","volume":"35","author":"SF Mahmood","year":"2014","unstructured":"Mahmood SF, Gruel N, Chapeaublanc E et al (2014) A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation. Carcinogenesis 35:670\u2013682. https:\/\/doi.org\/10.1093\/carcin\/bgt351","journal-title":"Carcinogenesis"},{"key":"3928_CR17","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1158\/0008-5472.CAN-06-3884","volume":"67","author":"S Ohtani","year":"2007","unstructured":"Ohtani S, Iwamaru A, Deng W et al (2007) Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy. Cancer Res 67:6293\u20136303. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3884","journal-title":"Cancer Res"},{"key":"3928_CR18","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa046.1194","author":"KCV Olarte","year":"2020","unstructured":"Olarte KCV, Bagamasbad PD (2020) SAT-132 the secretory vesicle membrane protein, CYB561, promotes the growth and metastatic potential of castration-resistant neuroendocrine prostate cancer. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvaa046.1194","journal-title":"J Endocr Soc"},{"key":"3928_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/jid.2013.375","volume":"134","author":"ME Polak","year":"2014","unstructured":"Polak ME, Thirdborough SM, Ung CY et al (2014) Distinct molecular signature of human skin langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation. J Investig Dermatol 134:695\u2013703. https:\/\/doi.org\/10.1038\/jid.2013.375","journal-title":"J Investig Dermatol"},{"key":"3928_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0306-4522(87)90205-3","volume":"22","author":"RM Pruss","year":"1987","unstructured":"Pruss RM, Shepard EA (1987) Cytochrome b561 can be detected in many neuroendocrine tissues using a specific monoclonal antibody. Neuroscience 22:149\u2013157. https:\/\/doi.org\/10.1016\/0306-4522(87)90205-3","journal-title":"Neuroscience"},{"key":"3928_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/jclinpath-2015-203493","volume":"69","author":"J Raphael","year":"2016","unstructured":"Raphael J, Gong IY, Nofech-Mozes S et al (2016) Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer. J Clin Pathol 69:552\u2013555. https:\/\/doi.org\/10.1136\/jclinpath-2015-203493","journal-title":"J Clin Pathol"},{"key":"3928_CR22","first-page":"24","volume":"7","author":"DL Rimm","year":"2001","unstructured":"Rimm DL, Camp RL, Charette LA et al (2001) Tissue microarray: a new technology for amplification of tissue resources. Cancer J 7:24\u201331","journal-title":"Cancer J"},{"key":"3928_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S et al (2015) International TILs working group 2014. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs working group 2014. Ann Oncol 26:259\u2013271. https:\/\/doi.org\/10.1093\/annonc\/mdu450","journal-title":"Ann Oncol"},{"key":"3928_CR24","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/jnci\/djp335","volume":"101","author":"RM Simon","year":"2009","unstructured":"Simon RM, Paik S, Hayes DF (2009) Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 101:1446\u20131452. https:\/\/doi.org\/10.1093\/jnci\/djp335","journal-title":"J Natl Cancer Inst"},{"issue":"Pt 3","key":"3928_CR25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1042\/bj3030915","volume":"303","author":"M Srivastava","year":"1994","unstructured":"Srivastava M, Gibson KR, Pollard HB et al (1994) Human cytochrome b561: a revised hypothesis for conformation in membranes which reconciles sequence and functional information. Biochem J 303(Pt 3):915\u2013921. https:\/\/doi.org\/10.1042\/bj3030915","journal-title":"Biochem J"},{"key":"3928_CR26","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.7150\/thno.49451","volume":"10","author":"S Sui","year":"2020","unstructured":"Sui S, An X, Xu C et al (2020) An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Theranostics 10:11938\u201311949. https:\/\/doi.org\/10.7150\/thno.49451","journal-title":"Theranostics"},{"key":"3928_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B et al (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98-102. https:\/\/doi.org\/10.1093\/nar\/gkx247","journal-title":"Nucleic Acids Res"},{"key":"3928_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. Cancer J Clin 65:87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262","journal-title":"Cancer J Clin"},{"key":"3928_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCRESAHA.117.311949","volume":"122","author":"MP van den Berg","year":"2018","unstructured":"van den Berg MP, Almomani R, Biaggioni I et al (2018) Mutations in CYB561 causing a novel orthostatic hypotension syndrome. Circ Res 122:846\u2013854. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311949","journal-title":"Circ Res"},{"key":"3928_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149183","volume":"11","author":"S Willis","year":"2016","unstructured":"Willis S, Villalobos VM, Gevaert O et al (2016) Single gene prognostic biomarkers in ovarian cancer: a meta-analysis. PLoS One 11:e0149183. https:\/\/doi.org\/10.1371\/journal.pone.0149183","journal-title":"PLoS One"},{"key":"3928_CR31","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.febslet.2008.05.010","volume":"582","author":"S Wyman","year":"2008","unstructured":"Wyman S, Simpson RJ, McKie AT et al (2008) Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro. FEBS Lett 582:1901\u20131906. https:\/\/doi.org\/10.1016\/j.febslet.2008.05.010","journal-title":"FEBS Lett"},{"key":"3928_CR32","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1038\/bjc.2014.174","volume":"110","author":"DA Yardley","year":"2014","unstructured":"Yardley DA, Tripathy D, Brufsky AM et al (2014) Long-term survivor characteristics in HER2-positive metastatic breast cancer from regist HER. Br J Cancer 110:2756\u20132764. https:\/\/doi.org\/10.1038\/bjc.2014.174","journal-title":"Br J Cancer"},{"key":"3928_CR33","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/ijc.29227","volume":"136","author":"H Zeng","year":"2015","unstructured":"Zeng H, Zheng R, Guo Y et al (2015) Cancer survival in China, 2003\u20132005: a population based study. Int J Cancer 136:1921\u20131930. https:\/\/doi.org\/10.1002\/ijc.29227","journal-title":"Int J Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03928-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-03928-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03928-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:06:38Z","timestamp":1658117198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-03928-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3928"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-03928-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article was approved by the ethics committee of Affiliated Hospital of Qinghai University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}